Chief U.S./EU Regulatory Concerns for European Life Sciences Developers

Overview

Please join Goodwin’s Life Sciences group for a weekly webinar series that aims to provide a multidisciplinary outlook on top-of-mind issues facing European life sciences companies in the era of COVID-19. 

This webinar series will be hosted and moderated by Goodwin Life Sciences Corporate partner Robert Puopolo. In each webinar, he will be joined by Goodwin colleagues and other market leaders to delve into the pertinent capital markets, regulatory, IP, licensing and cross-border M&A issues affecting European life sciences companies. 

This Session

Please join Goodwin’s Life Sciences Corporate partner, Robert Puopolo in conversation with Goodwin’s Life Sciences FDA Regulatory partner, Julie Tibbets and Life Sciences Licensing and UK Regulatory partner, Tim Worden, along with Parexel International's Senior Vice President and Global Head Enterprise Account Group, Dr. Oliver Fuhrmann, to discuss FDA and EMA developments and guidance on product development, clinical trials, and trial management in light of the ongoing COVID-19 pandemic.

Request an Invitation